chr8-132572310-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_012472.6(DNAAF11):​c.1397T>C​(p.Ile466Thr) variant causes a missense change. The variant allele was found at a frequency of 0.1 in 1,611,468 control chromosomes in the GnomAD database, including 10,570 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2573 hom., cov: 32)
Exomes 𝑓: 0.095 ( 7997 hom. )

Consequence

DNAAF11
NM_012472.6 missense

Scores

11
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 5.93

Publications

17 publications found
Variant links:
Genes affected
DNAAF11 (HGNC:16725): (dynein axonemal assembly factor 11) The protein encoded by this gene contains several leucine-rich repeat domains and appears to be involved in the motility of cilia. Defects in this gene are a cause of primary ciliary dyskinesia-19 (CILD19). Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 4, 11 and 22. [provided by RefSeq, Apr 2016]
DNAAF11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 19
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019569993).
BP6
Variant 8-132572310-A-G is Benign according to our data. Variant chr8-132572310-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 260274.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.313 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF11NM_012472.6 linkc.1397T>C p.Ile466Thr missense_variant Exon 12 of 12 ENST00000620350.5 NP_036604.2 Q86X45-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF11ENST00000620350.5 linkc.1397T>C p.Ile466Thr missense_variant Exon 12 of 12 1 NM_012472.6 ENSP00000484634.1 Q86X45-1

Frequencies

GnomAD3 genomes
AF:
0.151
AC:
22926
AN:
152032
Hom.:
2568
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.318
Gnomad AMI
AF:
0.143
Gnomad AMR
AF:
0.0878
Gnomad ASJ
AF:
0.109
Gnomad EAS
AF:
0.0397
Gnomad SAS
AF:
0.109
Gnomad FIN
AF:
0.0558
Gnomad MID
AF:
0.104
Gnomad NFE
AF:
0.0924
Gnomad OTH
AF:
0.149
GnomAD2 exomes
AF:
0.0991
AC:
24690
AN:
249022
AF XY:
0.0986
show subpopulations
Gnomad AFR exome
AF:
0.315
Gnomad AMR exome
AF:
0.0542
Gnomad ASJ exome
AF:
0.109
Gnomad EAS exome
AF:
0.0459
Gnomad FIN exome
AF:
0.0592
Gnomad NFE exome
AF:
0.0939
Gnomad OTH exome
AF:
0.105
GnomAD4 exome
AF:
0.0952
AC:
138902
AN:
1459320
Hom.:
7997
Cov.:
31
AF XY:
0.0958
AC XY:
69526
AN XY:
725958
show subpopulations
African (AFR)
AF:
0.329
AC:
10949
AN:
33244
American (AMR)
AF:
0.0601
AC:
2660
AN:
44274
Ashkenazi Jewish (ASJ)
AF:
0.108
AC:
2797
AN:
26000
East Asian (EAS)
AF:
0.0306
AC:
1212
AN:
39666
South Asian (SAS)
AF:
0.114
AC:
9728
AN:
85704
European-Finnish (FIN)
AF:
0.0638
AC:
3402
AN:
53356
Middle Eastern (MID)
AF:
0.117
AC:
674
AN:
5756
European-Non Finnish (NFE)
AF:
0.0910
AC:
101096
AN:
1111040
Other (OTH)
AF:
0.106
AC:
6384
AN:
60280
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
5995
11989
17984
23978
29973
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3784
7568
11352
15136
18920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.151
AC:
22943
AN:
152148
Hom.:
2573
Cov.:
32
AF XY:
0.147
AC XY:
10924
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.317
AC:
13148
AN:
41446
American (AMR)
AF:
0.0876
AC:
1340
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
379
AN:
3472
East Asian (EAS)
AF:
0.0396
AC:
205
AN:
5174
South Asian (SAS)
AF:
0.109
AC:
525
AN:
4820
European-Finnish (FIN)
AF:
0.0558
AC:
592
AN:
10612
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0924
AC:
6282
AN:
68010
Other (OTH)
AF:
0.147
AC:
311
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
902
1804
2705
3607
4509
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.113
Hom.:
4954
Bravo
AF:
0.160
TwinsUK
AF:
0.0898
AC:
333
ALSPAC
AF:
0.0947
AC:
365
ESP6500AA
AF:
0.294
AC:
1297
ESP6500EA
AF:
0.0967
AC:
832
ExAC
AF:
0.105
AC:
12803
Asia WGS
AF:
0.0850
AC:
301
AN:
3476
EpiCase
AF:
0.0928
EpiControl
AF:
0.0995

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia 19 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 08, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.49
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.099
.;T;T;.
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.91
D;D;.;D
MetaRNN
Benign
0.0020
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.7
.;M;M;.
PhyloP100
5.9
PrimateAI
Uncertain
0.70
T
PROVEAN
Uncertain
-2.4
.;.;N;N
REVEL
Benign
0.22
Sift
Uncertain
0.0030
.;.;D;D
Sift4G
Uncertain
0.0040
D;D;D;D
Polyphen
0.97
.;D;D;.
Vest4
0.14
ClinPred
0.027
T
GERP RS
5.7
Varity_R
0.15
gMVP
0.24
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9297853; hg19: chr8-133584558; COSMIC: COSV51539954; COSMIC: COSV51539954; API